Single low-dose primaquine for malaria control in Africa: a systematic review of safety, efficacy and implementation barriers
Since 2012, the WHO has recommended a single low dose of primaquine (SLDPQ, 0.25 mg/kg) alongside artemisinin-based combination therapies (ACTs) to block Plasmodium falciparum transmission and combat artemisinin resistance. Despite its proven benefits, SLDPQ adoption in African malaria policies rema...
Saved in:
| Main Authors: | Alphonse Ouedraogo, Sodiomon Bienvenu Sirima, Joseph Nyandwi, Didier Ménard, Tianle Ye, Emmanuelle Caspar, Denis Niyomwungere, Lucas Thiebaut, Pierre-Emeric Strubel, Omega Raobela, Rianasoambolanoro Rakotosaona, Arsène Ratsimbasoa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-08-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/10/8/e020264.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
by: Walter R J Taylor, et al.
Published: (2021-09-01) -
Transplacental Transmission of Plasmodium falciparum in a Highly Malaria Endemic Area of Burkina Faso
by: Alphonse Ouédraogo, et al.
Published: (2012-01-01) -
Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations.
by: Yoel Lubell, et al.
Published: (2014-08-01) -
Malaria incidence in children in South-West Burkina Faso: comparison of active and passive case detection methods.
by: Alfred B Tiono, et al.
Published: (2014-01-01) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023-09-01)